Eli Lilly在印度的肥胖症药品销售量猛增60%, Eli Lilly's obesity drug sales in India surge 60%, highlighting rising demand amid high obesity rates.

Eli Lilly在印度销售肥胖药的比例上升了60%, 反映出印度日益需要抗肥胖药。 Eli Lilly's sales of its obesity drug in India have surged by 60%, reflecting the country's growing need for anti-obesity solutions. 由于肥胖率是世界上最高的国家之一,影响到大约15%的成年人,因此对有效治疗的需求正在上升。 With one of the world's highest obesity rates, affecting about 15% of adults, the demand for effective treatments is on the rise. 销售量的增加凸显了印度肥胖药物市场的增长潜力。 This increase in sales highlights the potential for growth in the obesity drug market in India.